Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma
Anticancer Research · 2025
DOI: 10.21873/anticanres.17860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Atsushi Miki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke, Japan; amiki@jichi.ac.j…. Hauptthemen laut MEDLINE: Bilirubin, Bile Duct Neoplasms, Klatskin Tumor, Serum Albumin.
Abstract (Originalsprache)
BACKGROUND/AIM: The Albumin-Bilirubin (ALBI) score was initially developed to estimate prognosis in patients with hepatocellular carcinoma. Recently, its prognostic relevance has been extended to intrahepatic cholangiocarcinoma; however, its impact on perihilar cholangiocarcinoma remains unclear. PATIENTS AND METHODS: A total of 71 patients who underwent hepatectomy for perihilar cholangiocarcinoma between 2007 and 2024 at Jichi Medical University were retrospectively analyzed. Preoperative blood samples were obtained within two weeks before surgery, after effective jaundice control. Survival outcomes were evaluated using the Kaplan-Meier method and compared with the log-rank test. Cox proportional hazards modeling was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for overall survival. RESULTS: Patients with ALBI Grade 1 had a significantly longer median survival time compared to those with ALBI Grade 2 or 3 (not reached vs. 45 months vs. 13 months, respectively; p=0.001). The prognostic nutritional index (PNI) was significantly lower in ALBI Grade 2/3 than in Grade 1 (41.6±5.7 vs. 49.5±5.9, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke, Japan; amiki@jichi.ac.jp.
- Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke, Japan.
- Division of Cell Biology and Anatomy, Jichi Medical University, Shimotsuke, Japan.
Zitieren
APA
Miki, A., Sakuma, Y., Teratani, T., Sasanuma, H., Nishimura, W., & Yamaguchi, H. (2025). Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17860
Vancouver
Miki A, Sakuma Y, Teratani T, Sasanuma H, Nishimura W, Yamaguchi H. Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma. Anticancer Research. 2025. doi:10.21873/anticanres.17860
BibTeX
@article{Miki2025,
author = {Miki, Atsushi and Sakuma, Yasunaru and Teratani, Takumi and Sasanuma, Hideki and Nishimura, Wataru and Yamaguchi, Hironori},
title = {Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17860}
}
EUVIMED